EUVIMEDEUVIMED entdecken
Open Access

Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer

Jennifer E Klomp iD, J Nathaniel Diehl iD, Jeffrey A Klomp iD, A Cole Edwards, Runying Yang iD, Alexis J Morales iD, Khalilah E Taylor iD, Kristina Drizyte-Miller iD, Kirsten L Bryant iD, Antje Schaefer iD, Jared L Johnson iD, Emily M Huntsman und 12 weitere

Science · 07.06.2024 · 384 (6700)

DOI: 10.1126/science.adk0850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 07.06.2024. Verfasst von Jennifer E Klomp und 23 weiteren Autor:innen. Beteiligte Einrichtung: Lineberger Comprehensive Cancer Center; University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Hauptthemen laut MEDLINE: Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinase 3, Pancreatic Neoplasms, Phosphoproteins. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To delineate the mechanisms by which the ERK1 and ERK2 mitogen-activated protein kinases support mutant KRAS–driven cancer growth, we determined the ERK-dependent phosphoproteome in KRAS-mutant pancreatic cancer. We determined that ERK1 and ERK2 share near-identical signaling and transforming outputs and that the KRAS-regulated phosphoproteome is driven nearly completely by ERK. We identified 4666 ERK-dependent phosphosites on 2123 proteins, of which 79 and 66%, respectively, were not previously associated with ERK, substantially expanding the depth and breadth of ERK-dependent phosphorylation events and revealing a considerably more complex function for ERK in cancer. We established that ERK controls a highly dynamic and complex phosphoproteome that converges on cyclin-dependent kinase regulation and RAS homolog guanosine triphosphatase function (RHO GTPase). Our findings establish the most comprehensive molecular portrait and mechanisms by which ERK drives KRAS-dependent pancreatic cancer growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Pancreatic NeoplasmsPhosphoproteinsProteomeProto-Oncogene Proteins p21(ras)AnimalsHumansMiceCell Line, TumorCyclin-Dependent KinasesMAP Kinase Signaling SystemMutationPhosphorylationHEK293 Cells

Substanzen

Cyclin-Dependent KinasesKRAS protein, humanMAPK1 protein, humanMAPK3 protein, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PhosphoproteinsProteomeProto-Oncogene Proteins p21(ras)

Autor:innen und Institutionen

  • Lineberger Comprehensive Cancer Center; University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Cell Biology and Physiology Curriculum, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

ORCID-Profile: Jennifer E Klomp, J Nathaniel Diehl, Jeffrey A Klomp, Runying Yang, Alexis J Morales, Khalilah E Taylor, Kristina Drizyte-Miller, Kirsten L Bryant, Antje Schaefer, Jared L Johnson, Tomer M Yaron, Elisa Baldelli, Natalie K Barker, Laura E Herring, Lee M Graves, Lewis C Cantley, Adrienne D Cox, Channing J Der, Clint A Stalnecker

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Klomp, J. E., Diehl, J. N., Klomp, J. A., Edwards, A. C., Yang, R., Morales, A. J., Taylor, K. E., Drizyte-Miller, K., Bryant, K. L., Schaefer, A., Johnson, J. L., Huntsman, E. M., Yaron, T. M., Pierobon, M., Baldelli, E., Prevatte, A. W., Barker, N. K., Herring, L. E., Petricoin, E. F., …, & Stalnecker, C. A. (2024). Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer. Science, 384(6700). https://doi.org/10.1126/science.adk0850

Vancouver

Klomp JE, Diehl JN, Klomp JA, Edwards AC, Yang R, Morales AJ, et al. Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer. Science. 2024;384(6700). doi:10.1126/science.adk0850

BibTeX
@article{Klomp2024,
  author = {Klomp, Jennifer E and Diehl, J Nathaniel and Klomp, Jeffrey A and Edwards, A Cole and Yang, Runying and Morales, Alexis J and Taylor, Khalilah E and Drizyte-Miller, Kristina and Bryant, Kirsten L and Schaefer, Antje and Johnson, Jared L and Huntsman, Emily M and Yaron, Tomer M and Pierobon, Mariaelena and Baldelli, Elisa and Prevatte, Alex W and Barker, Natalie K and Herring, Laura E and Petricoin, Emanuel F and Graves, Lee M and Cantley, Lewis C and Cox, Adrienne D and Der, Channing J and Stalnecker, Clint A},
  title = {Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer},
  journal = {Science},
  year = {2024},
  volume = {384},
  number = {6700},
  doi = {10.1126/science.adk0850}
}
Kostenlos starten →